Bakhoum, Samuel F. https://orcid.org/0000-0002-4779-8422
Article History
First Online: 29 December 2025
Competing interests
: S.F.B. is a co-founder, chief scientific officer and a member of the board of directors at Volastra Therapeutics Inc., where he owns equity and from which he receives compensation. He also serves on the scientific advisory board of Meliora Therapeutics and Arinale Biosciences Inc. The work presented herein is unrelated to these affiliations, and these entities had no role in the conception, conduct or reporting of this research.